Donate to HSC
Donate to HSC
Facebook
Twitter
Instagram

Biosimilars – Advocacy

The Patient Protection and Affordable Care Act (ACA) established a new regulatory pathway for a class of drugs known as biosimilars. Biosimilars, also known as “follow on biologics,” are medicines that are similar to, but not exact copies of, biologically derived...